HHLR ADVISORS, LTD. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$350,739,000
+0.3%
2,962,0760.0%3.47%
+24.6%
Q4 2020$349,851,000
+6.3%
2,962,0760.0%2.78%
+11.5%
Q3 2020$329,205,000
+8.8%
2,962,0760.0%2.49%
-9.9%
Q2 2020$302,665,000
+1.9%
2,962,076
+7.7%
2.77%
-30.9%
Q1 2020$296,937,000
-7.3%
2,751,2000.0%4.00%
+0.3%
Q4 2019$320,185,000
+1.7%
2,751,2000.0%3.99%
-7.9%
Q3 2019$314,930,000
+20.1%
2,751,2000.0%4.33%
-26.2%
Q2 2019$262,189,000
+4.4%
2,751,2000.0%5.86%
-16.2%
Q1 2019$251,047,000
+20.2%
2,751,2000.0%6.99%
-19.3%
Q4 2018$208,844,0002,751,2008.66%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q4 2019.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders